Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings in Brief: ThermoLase

This article was originally published in The Gray Sheet

Executive Summary

ThermoLase: Agrees to acquire 10% stake in AntiCancer Inc. via a $4.4 mil. investment in the San Diego biotech firm. ThermoLase says a technology under development by AntiCancer "has potential to enhance the effectiveness of the Thira cream used in ThermoLase's SoftLight hair-removal process." AntiCancer technologies also show promise for use in "permanent hair coloring and for enhanced hair growth," ThermoLase says, noting that it has entered a separate agreement licensing the technology for "these and other potential hair-related products." The exclusive, worldwide licensing agreement calls for ThermoLase to pay $100,000 up front and up to $1.5 mil. in milestone payments, as well as royalty payments on "any products developed"...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts